We are live on ! Find out more
CL

CSS LLC Portfolio holdings

AUM $2.57B
1-Year Est. Return 67.1%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+67.1%
3 Year Est. Return
+128.35%
5 Year Est. Return
+164.54%
10 Year Est. Return
+489.68%
AUM
$1.77B
AUM Growth
+$498M
Cap. Flow
-$274M
Cap. Flow %
-15.54%
Top 10 Hldgs %
26.95%
Holding
831
New
227
Increased
117
Reduced
127
Closed
184
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
226
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$770K 0.04%
+30,000
New +$607K
GRX
227
Gabelli Healthcare & Wellness Trust
GRX
$141M
$762K 0.04%
75,881
+1,265
+2% +$12.5K
ELAN icon
228
Elanco Animal Health
ELAN
$11.4B
$761K 0.04%
+35,455
New +$783K
LSXMK
229
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$749K 0.04%
28,077
+19,812
+240% +$510K
DNI
230
DELISTED
Dividend and Income Fund
DNI
$746K 0.04%
73,319
-7,808
-10% -$75.8K
TWO
231
DELISTED
Two Harbors Investment
TWO
$733K 0.04%
36,368
+8,368
+30% +$155K
AA icon
232
Alcoa
AA
$12.2B
$732K 0.04%
65,162
-6,300
-9% -$56.3K
EOG icon
233
CALL
EOG Resources
EOG
$76B
$730K 0.04%
+14,400
New +$698K
REZI icon
234
Resideo Technologies
REZI
$2.83B
$724K 0.04%
61,758
-8,881
-13% -$61.8K
ZGNX
235
DELISTED
Zogenix, Inc.
ZGNX
$717K 0.04%
+26,536
New +$732K
BTAI
236
PUT
DELISTED
BioXcel Therapeutics
BTAI
$716K 0.04%
+844
New +$550K
BMY icon
237
Bristol-Myers Squibb
BMY
$130B
$712K 0.04%
12,100
-4,300
-26% -$257K
WSO.B
238
Watsco Inc Class B
WSO.B
$709K 0.04%
3,971
FDX icon
239
PUT
FedEx
FDX
$71.4B
$702K 0.04%
+5,000
New +$629K
RITM icon
240
Rithm Capital
RITM
$5.29B
$699K 0.04%
+94,100
New +$609K
FTV icon
241
CALL
Fortive
FTV
$16.7B
$690K 0.04%
+16,175
New +$631K
INO icon
242
CALL
Inovio Pharmaceuticals
INO
$119M
$689K 0.04%
2,133
+2,000
+1,504% +$321K
CNST
243
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$677K 0.04%
+22,542
New +$812K
INO icon
244
PUT
Inovio Pharmaceuticals
INO
$119M
$674K 0.04%
2,083
-4,275
-67% -$686K
CACC icon
245
PUT
Credit Acceptance
CACC
$6.24B
$670K 0.04%
+1,600
New +$557K
HCA icon
246
CALL
HCA Healthcare
HCA
$93.2B
$670K 0.04%
6,900
ITCI
247
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$664K 0.04%
25,885
+2,303
+10% +$46.6K
VTA
248
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$653K 0.04%
73,352
-25,097
-25% -$214K
MT icon
249
ArcelorMittal
MT
$55.1B
$652K 0.04%
+60,734
New +$612K
BKNG icon
250
Booking.com
BKNG
$129B
$650K 0.04%
10,200
+175
+2% +$10.7K

Similar funds

CSS LLC's Q2 2020 Portfolio in Review

As of Q2 2020, CSS LLC held 831 positions worth $1.77B, up 39% from $1.27B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

CSS LLC withdrew a net $274M in Q2 2020, closing 184 positions and reducing 127 holdings. Its most notable exit was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6, an estimated $44.5M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, down from 86% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, CSS LLC opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $29.4M.

  • CSS LLC's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 23,414 shares worth $29.4M.
  • CSS LLC added most to Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A in Q2 2020, an estimated $55.5M increase.
  • CSS LLC's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $5.55M.
  • CSS LLC fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 in Q2 2020, selling an estimated $44.5M.
  • CSS LLC's ten largest holdings make up 27% of its $1.77B portfolio in Q2 2020.
  • CSS LLC opened 227 new positions and closed 184 in Q2 2020.
  • CSS LLC's portfolio value rose 39% quarter-over-quarter to $1.77B.

Based on CSS LLC's 13F filing for Q2 2020, filed 14 Aug 2020.